Profil
- ul. Kopcińskiego 22
90-153 Łódź
Mariola Świderek-Matysiak
dr hab. n. med.- Neurologia
- Polskie Towarzystwo Neurologiczne – członek od 1998 roku
- European Committee for Treatment and Research in MS.
- Swiderek M, Kozubski W, Watala C. Abnormalities in membrane structure and function in Alzheimer’s disease and ischaemic stroke. Platelets, 1997, 8, 125-133 pr.poglądowa IF 2.374
- Kozubski W, Swiderek M, Watala C. Otępienie a właściwości błon biologicznych. Terapia 1998; 7-9 pr.poglądowa
- Kozubski W, Swiderek M, Kloszewska I, Watala C, Gwozdzinski K. [Platelet membrane fluidity and receptor exposition in patients with Alzheimer's disease] Neurol Neurochir Pol. 1999 Nov-Dec;33(6):1275-84. pr. oryginalna
- Kozubski W, Swiderek M, Kloszewska I, Gwozdzinski K, Watala C. Blood platelet membrane fluidity and the exposition of membrane protein receptors in Alzheimer disease (AD) patients--preliminary Study. Alzheimer Dis Assoc Disord. 2002 Jan-Mar;16(1):52-4. pr. oryginalna IF 1.962 MNiSW 10
- Matysiak M, Jurewicz A, Jaskolski D, Selmaj K. TRAIL induces death of human oligodendrocytes isolated from adult brain. Brain. 2002 Nov;125(Pt 11):2469-80. pr. oryginalna IF 7,122 MNiSW 21
- Jurewicz A, Matysiak M, Tybor K, Selmaj K. TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3. Brain. 2003 Jun;126(Pt 6):1358-70. pr. oryginalna IF 7,967 MNiSW 22
- Jurewicz A, Matysiak M, Tybor K, Kilianek L, Raine CS, Selmaj K. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain. 2005 Nov;128(Pt 11):2675-88. pr. oryginalna IF 7,535 MNiSW 24
- Jurewicz A, Matysiak M, Andrzejak S, Selmaj K. TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. Glia. 2006; 53:158-166 pr. oryginalna IF 5,013 MNiSW 24
- Jurewicz A, Matysiak M, Raine C, Selmaj K. Soluble Nogo-A, an inhibitor of axonal regeneration, as biomarker for multiple sclerosis. Neurology 2007; 68: 283-287 pr. oryginalna IF 6,014 MNiSW 24
- Matysiak M, Stasiołek M, Orłowski W, Jurewicz A, Janczar Sz, Raine CS, Selmaj K. Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism. J Neuroimmunol , 2008, Jan;193(1-2):12-23. pr. oryginalna IF 3,159 MNiSW 20
- Matysiak M, Makosa B, Walczak A, Selmaj K. Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex. Mult Scler. 2008 14(7): 919-26 pr. oryginalna IF 3,312 MNiSW 24
- Selmaj K, Jurewicz A, Matysiak M, Raine CS. Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis. Neurology 2009; 72(19):1708-09 odpowiedź dla autora IF 8.172
- Cwiklinska H, Mycko M, Szymanska B, Matysiak M, Selmaj K. Aberrant Stress-Induced Hsp70 Expression In Immune Cells In MS. J Neurosci Res. 2010 Nov 1;88(14):3102-10. pr. oryginalna IF 2,958 MNiSW 27
- Matysiak M, Orlowski W, Fortak-Michalska M, Jurewicz A, Selmaj K. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J Neuroimmunol 2011 233:106-111 pr. oryginalna IF 2,959 MNiSW 25
- Matysiak M, Fortak-Michalska M, Szymanska B, Orlowski W, Jurewicz A, Selmaj K. MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase-2. J Immunol. 2013 15;190(10):5102-9 pr. oryginalna IF 5,362 MNiSW 35
- Mycko MP, Cwiklinska H, Cichalewska M, Matysiak M, Lewkowicz P, Sliwinska B, Selmaj I, Selmaj KW. Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients. Clin Immunol. 2014 Jul;153(1):211-9 pr.oryginalna IF 3,992 MNiSW 30
- Lewkowicz N, Mycko MP, Przygodzka P, Ćwiklińska H, Cichalewska M, Matysiak M, Selmaj K, Lewkowicz P. Induction of human IL-10-producing neutrophils by LPS-stimulated Treg cells and IL-10.Mucosal Immunol. 2016 Mar;9(2):364-78
- Publikacja książka: Stwardnienie rozsiane ; wydawnictwo Termedia 2013 Rozdział: Komórki macierzyste – postęp czy regres w terapii stwardnienia rozsianego? Autor: Mariola Świderek-Matysiak str. 109-118 Rozdział: NOGO-nowy biomarker stwardnienia rozsianego. Autorzy: Anna Jurewicz, Mariola Świderek-Matysiak, Krzysztof Selmaj str. 25-30